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Introduction: Chest pain (CP) patients in the Emergency Department (ED) present a diagnostic 
dilemma, with a low prevalence of coronary disease but grave consequences with misdiagnosis. A 
common diagnostic strategy involves ED cardiac monitoring while excluding myocardial necrosis, 
followed by stress testing. We sought to describe the use of stress echocardiography (echo) at our 
institution, to identify cardiac pathology compared with stress electrocardiography (ECG) alone. 
Methods:	Retrospective cohort study of 57 urban ED Chest Pain Unit (CPU) patients from 2002-
2005 with stress testing suggesting ischemia. Our main descriptive outcome was proportion and type 
of discordant findings between stress ECG testing and stress echo. The secondary outcome was 
whether stress echo results appeared to change management. 
Results: Thirty-four of 57 patients [59.7%, 95% confidence interval (CI) 46.9-72.4%] had stress 
echo results discordant with stress ECG results. The most common discordance was an abnormal 
stress ECG with a normal stress echo (n=17/57, 29.8%, CI 17.9-41.7%), followed by normal stress 
ECG but with reversible regional wall-motion abnormality on stress echo (n = 10/57, 17.5%, CI 7.7-
27.4%). The remaining seven patients (12.3%, CI 3.8-20.8%) had non-diagnostic stress ECG due 
to sub-maximal effort. Stress echo showed reversible wall-motion abnormality in two, and five were 
normal. Twenty-five of the 34 patients (73.5%, CI 56.8-85.4%) with discordant results had a different 
diagnostic strategy than predicted from their stress ECG alone.
Conclusion:	The addition of echo to stress ECG testing in ED CPU patients altered diagnosis in 
34/57 (59.7%, CI 46.9-72.4%) patients, and appeared to change management in 25/57 (43.9%, CI 
31.8-57.6%) patients. [West J Emerg Med. 2010; 11(4):379-383.]
INTRODUCTION
Chest pain (CP) is a common presenting symptom in 
emergency department (ED) patients, accounting for 5.4% of 
all ED visits.1 These patients present a diagnostic dilemma, as 
the prevalence of coronary artery disease (CAD) is low but the 
consequence of misdiagnosis is high.2 After history, physical 
examination, electrocardiogram (ECG) and cardiac markers, 
most patients are found to be low risk for acute coronary 
syndrome. Many EDs use stress ECG alone to further risk-
stratify this group and determine which patients need coronary 
angiography (CA) or admission. Although CA is considered 
the criterion reference in CAD diagnosis, it is invasive and 
expensive.3 
According to American Heart Association/American 
College of Cardiology guidelines, exercise ECG is the first test 
for evaluation of known or suspected CAD. Patients must 
reach greater than 85% of their maximum heart rate on a 
treadmill or exercise bicycle for optimal stress.4 Stress ECG is 
considered positive with reversible, regional ST changes 
suggesting ischemia, but it has demonstrated sensitivity and Western Journal of Emergency Medicine  380  Volume XI, no. 4  :  September 2010
specificity of 68% and 77%, respectively.5 When applied to a 
CPU population with low prevalence of disease, stress ECG 
yields many false-positives.
The addition of echocardiograph (echo) to stress ECG 
testing may reveal cardiac pathology and potentially better 
inform the decision to perform CA. Stress echo shows left 
ventricular systolic and diastolic dysfunction, valvular 
problems, infarction and stress-induced ischemia.4 It also 
discovers other cardiovascular diagnoses, such as pericardial 
effusion or aortic dissection. Reversible regional wall motion 
abnormalities indicate myocardial ischemia and last up to two 
minutes or until heart rate drops from maximal. The sensitivity 
and specificity of stress echo for CAD improves modestly to 
79.1% and 87.1%, respectively, over stress ECG testing 
alone.6 
Previous studies have compared stress ECG alone with 
the combination of stress ECG and echo, 7, 8 but no study 
has compared the two in ED patients. We describe the use of 
stress echo, at our institution, to identify cardiac pathology 
compared with stress ECG, and its apparent effect on patient 
management. 
METHODS
We conducted a retrospective cohort study of CP patients 
who also had an abnormal stress test result, either ECG stress 
test or stress echo and admitted to the CPU between January 
1, 2002 and December 31, 2005. In the judgment of the 
attending emergency physician (EP), these patients’ 
presentations warranted diagnostic testing for CAD (initial 
and six-hour ECG, initial chest radiography, and initial and 
six-hour creatine phosphokinase-MB fraction and Troponin I) 
but were all negative. We performed the study in a 35-bed 
tertiary care ED, with a census of 38,000 patients per year, 
supporting a postgraduate year 1-3 emergency medicine 
residency. The CPU protocol ended with a stress echo in all 
cases. Patients had a resting echo, followed immediately with 
stress by treadmill or, for those unable to walk or run, with 
intravenous dobutamine. We considered treadmill and 
dobutamine equivalent stressors. Finally, the echo was 
repeated immediately with rapid heart rate to assess 
tachycardia-induced regional wall motion. Nuclear studies 
were not part of the CPU protocol at our institution.
We included all patients with positive stress tests of either 
type during calendar years 2002-2005, drawn from the 
cardiology stress test database (n=57). The cardiac stress lab 
personnel searched the database for either abnormal stress test 
component. A positive stress ECG was defined as a >1 mm of 
horizontal or downsloping ST-segment depression or elevation 
for at least 60 to 80 milliseconds after the end of the QRS 
complex.9 A positive stress echo was defined as normal resting 
wall motion but reversible hypokinesis or akinesis after 
exercise or dobutamine.10 We did not include any patients with 
nuclear imaging as CPU patients all undergo stress echo 
testing, nor exclude any patients with either a positive stress 
ECG or positive stress echo.
Patients were aged 30-76 (mean = 54). Twenty-seven 
were female (47.3%). Ethnicity was 59.6% Caucasian (n = 
34), 17.5% Hispanic (n = 10), 10.5% Asian (n = 6), 8.8% 
African-American (n = 5), and 3.5% other (n = 2). 
A single investigator (EKW, a fourth-year medical student 
with research experience) abstracted ED and hospital charts 
and computerized ECG and stress echo repots directly into an 
Excel spreadsheet (Microsoft Corporation, Redmond, WA) 
with standardized data elements. We recorded patient 
demographics, disposition, stress ECG and stress echo 
findings. We searched computerized records for CA reports 
after stress testing on all patients through 2007; if absent, we 
presumed they were not done at our institution. We included 
data from only one CP evaluation per patient. We did not have 
access to stress test or CA results outside our institution.
A senior emergency medicine resident assisted the 
medical student in interpreting and categorizing the stress test 
reports based solely on the attending cardiologist’s 
interpretation. Non-diagnostic stress tests were those where 
the patient did not achieve 85% of their predicted maximum 
heart rate for age. As the data gathered were primarily 
objective, we did not need to resolve any ambiguities in the 
medical record. 
We conformed to most elements of optimum retrospective 
chart review. However, the chart abstracter was not blind to 
Figure	1.	Flowchart of patients. All negative stress echocardio-
graph patients were discharged home, while those with positive 
stress test components were admitted. Patients with changes to 
expected disposition after stress ECG alone in bold	(n=34):
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the hypothesis. As there was only one data abstracter and the 
data were objective, we did not test intrarater agreement, nor 
periodically monitor the data abstracter. 11, 12
We determined concordance between stress ECG and 
echo and whether the stress echo results provided evidence 
that would customarily lead to change in clinical management. 
Concordance was defined as both the ECG and echo 
components showing ischemic changes and reversible regional 
wall motion abnormality in similar coronary distributions. 
Stress echo results that identified reversible regional wall 
motion abnormality in the absence of ST segment ischemic 
changes were deemed discordant, as was a normal or 
abnormal stress echo in the face of suboptimal exercise level. 
Change in clinical management was defined as admission to 
the hospital from the CPU rather than customary discharge 
home or performance of CA. It was presumed that CPU 
patients would be discharged home if the stress echo were 
normal. Any admission or CA following the stress echo was 
therefore considered a change in clinical management. The 
local Institutional Review Board approved the study.
RESULTS
During calendar years 2002-2005, approximately 1,300 
stress tests were done from the CPU, of which 57 (4.4%) had 
at least one component of stress testing that was abnormal, 
either an abnormal stress ECG, abnormal stress echo or both, 
and formed our study population. In 34/57 patients, the echo 
findings were discordant with stress ECG test results (59.7%, 
CI 46.9-72.4%), while in the remaining 23 CPU patients, the 
stress ECG and stress echo components were both abnormal. 
The most common discordance was an abnormal stress 
ECG with a normal echo (n= 17/57, 29.8%, CI 17.9-41.7%), 
followed by normal stress ECG but with reversible regional 
wall-motion abnormality on stress echo (n= 10/57, 17.5%, CI 
7.7-27.4%). The remaining seven patients (12.3%, CI 3.8-
20.8%) had non-diagnostic stress ECG due to sub-maximal 
effort. Stress echo showed reversible wall-motion abnormality 
in two, and five were normal. Twenty-five of the 34 patients 
(73.5%, CI 56.8-85.4%) with discordant results had a 
different disposition than predicted from their stress ECG 
alone. Additionally, stress echo discovered moderate mitral 
regurgitation in two patients. No patient had CA based on 
the stress ECG component alone; all 57 patients got the echo 
component both before and after stress.
DISCUSSION
The addition of stress echo provided additional 
information about cardiac pathology in 34 of 57 patients 
(59.7%). It discovered reversible wall motion abnormalities in 
patients with normal stress ECG findings. The echo 
component seemed to provide sufficient reassurance for the 
EPs to feel comfortable discharging the patient home with no 
further non-invasive testing or CA.
Echo also found valvular pathology that cannot be 
assessed with ECG.
Two previous studies of non-ED patients made similar 
comparisons between stress echo and stress ECG tests.7, 8 
These studies of higher risk patients had CAD rates of 71.2% 
and 57.3%, respectively, far higher than our ED CPU 
population. Salustri et al. found a lower rate of discordance 
between the two tests (n= 7/35, 20%) than we did (59.7%), 
while Severi’s published data preclude calculation of a 
discordance rate. However, at least 16.1% of his patients must 
have had discordance, while the true rate was likely much 
higher. Seven of our 34 discordant findings (20.6%) were 
equivocal stress ECG tests limited by exercise tolerance. 
Salustri reported no patients with equivocal stress ECG tests, 
while Severi reported 7.0%, both unrealistically low in our 
experience. Whether we consider all of our equivocal stress 
ECG tests as positives or negatives, our discordant rate is 
largely unchanged, 58.2% and 55.7%, respectively. Neither of 
these studies commented on additional anatomical findings 
with stress echo, while we found two patients with valvular 
disease.
Adding echo to standard ECG stress testing more than 
doubles the charges at our institution, from $1,103 to $2,299, 
including professional and technical fees. Despite this, stress 
echo is supported in the literature as cost-effective.3 After 
studying 429 patients in 1994, Severi postulated that, while 
stress echo outperformed stress ECG as a diagnostic test, the 
latter would still remain first line for screening due to lower 
cost.7 However, a 2008 economic analysis of strategies to 
diagnose CAD, including non-invasive ECG, echo, and 
nuclear imaging, as well as CA, found pharmacological stress 
echo to be the most cost-effective. Exercise stress echo was 
found to be 1.5 times the cost of pharmacological stress echo, 
while exercise stress ECG was 3.5 times higher, due to 
false-positives requiring CA. The same study found the cost of 
a primary CA strategy after history, physical, resting ECG, and 
cardiac markers, to be 56.3 times higher than pharmacological 
stress echo.13 
Lewandowski, et al. reported an economic-analysis of 
diagnostic screening for CAD in 551 patients, beginning with 
baseline risk. CPU patients, who are already deemed low risk 
(<10% prevalence of CAD), can be further risk-stratified by 
gender, since at any age CAD is less common in women. 
Therefore, this approach recommends stress ECG in males 
(94% sensitivity, 27% specificity), but stress echo in females 
(79% sensitivity, 71% specificity) increases specificity and 
avoids pursuit of false-positive results.3 This differential 
approach by gender increases the specificity in women from 
16% with stress ECG to 71% with stress echo, without 
sacrificing sensitivity (91% vs. 79% respectively, p = NS)
In our study, 25/34 patients with discordant stress test 
results had a different clinical course than predicted from 
stress ECG results alone. We presumed that 17 positive stress 
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ECG tests would have required CA, but 16 did not when the 
echo component was negative. Five of seven with non-
diagnostic ECG stress tests also would have customarily had 
CA to clarify pathology, but echo changed their management, 
as one had CA after positive stress echo, while four did not 
when the stress echo was normal. Of 10 more with normal 
stress ECG and abnormal stress echoes, four had CA. The 
other six should have had CA but did not at our institution. 
Therefore, routine stress echo in addition to stress ECG testing 
is supported by the bulk of previous literature, and is used at 
our institution to guide patient management. All CA for our 
patients was performed during the hospitalization following 
the abnormal stress echo test.
The addition of echo to stress ECG identified cardiac 
pathology in CPU patients and may have been used to avoid 
CA and hospital admission in our institution. This strategy 
appears to be cost-effective. However, a prospective study that 
compares both test components to a criterion reference of CA 
with clinical outcome is required to validate this approach. 
LIMITATIONS
Our study had major limitations. As a retrospective 
review, the data in the computerized medical record was 
incomplete. Many of our patients did not undergo CA, even if 
the non-invasive testing indicated it. This, in turn, precluded 
determination of the test characteristics of stress testing for 
CAD. In addition, we could not determine the treating 
physicians’ pre-test treatment plans. Hence, assertions that the 
stress echo changed management are speculative and based on 
our view of customary practice. 
By searching the cardiology database to identify patients 
with abnormal stress test results, it is possible that we omitted 
some patients who should have been included. The Director of 
Cardiac Stress Testing laboratory is facile with the database, 
but there has been no validation of the search strategy to 
assure that it captures all appropriate patients.
While some exercise ECG stress tests were indeterminate 
due to failure to achieve the target heart rate, the same 
limitation would apply to the echo portion of these patients’ 
tests, limiting the sensitivity to identify acute coronary 
syndrome at maximal load. That our cardiologists felt 
comfortable calling a stress echo negative short of the target 
heart rate has not been validated. Therefore, the disposition of 
five patients in the study with non-diagnostic stress ECGs 
appears unsupported by non-invasive testing. 
As with all non-invasive testing to risk stratify CP 
patients, the approach in our institution leads to discharge of 
some patients with coronary disease. This is inherent in the 
limited sensitivity of diagnostic testing, whether for cardiac 
problems or otherwise. Hence, it is prudent to advise all 
discharged patients of the warning signs to return to the ED 
immediately and not to portray the diagnostic workup as 
“negative,” but rather “very low risk.”
The cardiologists reading stress echo tests were subject to 
incorporation bias, as they were aware of results of the stress 
ECG tests. We assumed that reversible regional wall motion 
abnormality on stress echo represented acute ischemia and 
suggested CAD. However, the echo findings may have been 
incidental, and reflected asymptomatic or chronic CAD.
Our study was too small to address which type of patient 
might benefit from the stress echo versus stress ECG alone. 
We did not, for example, stratify our patients by age, sex or 
beta-blocker use. This paper describes customary practice at 
one institution and should not be generalized.
CONCLUSION
In 59.7% of ED CPU patients in our institution, we found 
that stress echo testing was used to justify either patient 
discharge home or the need for admission or CA and to 
identify valvular pathology. Furthermore, stress echo appeared 
to alter disposition in 74% of patients who had discordant 
stress ECG and stress echo results. As this is a description 
of one institution’s approach to risk stratification of CP 
patients, this report should not be construed to validate such 
an approach. We recommend a prospective study of a larger 
sample to answer the question whether the addition of echo to 
ECG stress testing provides accurate information and to assess 
the test characteristics of stress echo and stress ECG alone 
compared to a criterion reference of CA with clinical follow 
up.
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